166 related articles for article (PubMed ID: 32221841)
1. Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice.
Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Świąder K; Wróbel A; Szponar J; Doboszewska U; Wlaź P; Wlaź A; Serefko A
Pharmacol Rep; 2020 Dec; 72(6):1562-1572. PubMed ID: 32221841
[TBL] [Abstract][Full Text] [Related]
2. Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice.
Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Sobczyński J; Wróbel A; Doboszewska U; Wlaź P; Wlaź A; Szponar J; Skałecki P; Serefko A
Behav Brain Res; 2020 Jan; 378():112297. PubMed ID: 31626848
[TBL] [Abstract][Full Text] [Related]
3. The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice.
Poleszak E; Szopa A; Wyska E; Wośko S; Serefko A; Wlaź A; Pieróg M; Wróbel A; Wlaź P
Life Sci; 2015 Sep; 136():13-8. PubMed ID: 26135623
[TBL] [Abstract][Full Text] [Related]
4. Influence of the CB
Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Świąder K; Wróbel A; Doboszewska U; Wlaź P; Wlaź A; Serefko A
Pharmacol Biochem Behav; 2020 Jan; 188():172833. PubMed ID: 31785246
[TBL] [Abstract][Full Text] [Related]
5. Influence of the CB
Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Doboszewska U; Wlaź P; Wlaź A; Dudka J; Szponar J; Serefko A
Brain Res Bull; 2019 Aug; 150():179-185. PubMed ID: 31158462
[TBL] [Abstract][Full Text] [Related]
6. CB
Wośko S; Serefko A; Szopa A; Wlaź P; Wróbel A; Wlaź A; Górska J; Poleszak E
J Pharm Pharmacol; 2018 Apr; 70(4):566-575. PubMed ID: 29380383
[TBL] [Abstract][Full Text] [Related]
7. Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice.
Stasiuk W; Szopa A; Serefko A; Wyska E; Świąder K; Dudka J; Wlaź P; Poleszak E
J Neural Transm (Vienna); 2017 Mar; 124(3):387-396. PubMed ID: 27900470
[TBL] [Abstract][Full Text] [Related]
8. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
Cryan JF; Page ME; Lucki I
Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105
[TBL] [Abstract][Full Text] [Related]
9. The influence of selective A1 and A2A receptor antagonists on the antidepressant-like activity of moclobemide, venlafaxine and bupropion in mice.
Bogatko K; Poleszak E; Szopa A; Wyska E; Wlaź P; Świąder K; Wlaź A; Doboszewska U; Rojek K; Serefko A
J Pharm Pharmacol; 2018 Sep; 70(9):1200-1208. PubMed ID: 29943503
[TBL] [Abstract][Full Text] [Related]
10. Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.
Umathe SN; Manna SS; Jain NS
Behav Brain Res; 2011 Sep; 223(1):125-34. PubMed ID: 21549765
[TBL] [Abstract][Full Text] [Related]
11. Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice.
Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
Pharmacol Biochem Behav; 2012 Dec; 103(2):273-8. PubMed ID: 22940586
[TBL] [Abstract][Full Text] [Related]
12. Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice.
Roni MA; Rahman S
Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):1-6. PubMed ID: 26455278
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system.
Kruk-Slomka M; Michalak A; Biala G
Behav Brain Res; 2015 May; 284():24-36. PubMed ID: 25660201
[TBL] [Abstract][Full Text] [Related]
14. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
[TBL] [Abstract][Full Text] [Related]
15. The depressogenic-like effect of acute and chronic treatment with dexamethasone and its influence on the activity of antidepressant drugs in the forced swim test in adult mice.
Wróbel A; Serefko A; Wlaź P; Poleszak E
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():243-8. PubMed ID: 24984273
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and biochemical studies of dichloromethane fraction from the Areca catechu nut.
Dar A; Khatoon S
Pharmacol Biochem Behav; 2000 Jan; 65(1):1-6. PubMed ID: 10638628
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice.
Villarinho JG; Fachinetto R; de Vargas Pinheiro F; da Silva Sant'Anna G; Machado P; Dombrowski PA; da Cunha C; de Almeida Cabrini D; Pinto Martins MA; Gauze Bonacorso H; Zanatta N; Antonello Rubin M; Ferreira J
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):31-9. PubMed ID: 22525823
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901
[TBL] [Abstract][Full Text] [Related]
19. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
[TBL] [Abstract][Full Text] [Related]
20. Failure to detect the action of antidepressants in the forced swim test in Swiss mice.
Suman PR; Zerbinatti N; Theindl LC; Domingues K; Lino de Oliveira C
Acta Neuropsychiatr; 2018 Jun; 30(3):158-167. PubMed ID: 29202894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
